These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 404372)

  • 1. Immunochemical studies on the nature of the serum component (SAA) related to secondary amyloidosis.
    Ignaczak TF; Sipe JD; Linke FP; Glenner GG
    J Lab Clin Med; 1977 May; 89(5):1092-1104. PubMed ID: 404372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation and structural properties of murine SAA--the acute phase serum precursor of amyloid AA.
    Sipe JD; McAdam KP; Torain BF; Pollock PS
    Immunol Commun; 1977; 6(1):1-12. PubMed ID: 863470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amyloid fibril protein AA: purification and properties of the antigenically related serum component as determined by solid phase radioimmunoassay.
    Sipe JD; Ignaczak TF; Pollock PS; Glenner GG
    J Immunol; 1976 Apr; 116(4):1151-6. PubMed ID: 1254964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conformational flexibility of the serum amyloid precursor SAA.
    Sipe JD; McAdam KP; Torain BF; Glenner GG
    Br J Exp Pathol; 1976 Oct; 57(5):582-92. PubMed ID: 999792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum amyloid A protein in amyloidosis, rheumatic, and enoplastic diseases.
    Benson MD; Cohen AS
    Arthritis Rheum; 1979 Jan; 22(1):36-42. PubMed ID: 103558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antigenic difference between serum amyloid protein SSA and its low molecular weight derivative SAAL revealed by an anti-amyloid A antiserum at different temperatures.
    Linke RP
    Z Immunitatsforsch Immunobiol; 1978 Mar; 154(2):169-72. PubMed ID: 77090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein.
    Gillmore JD; Lovat LB; Persey MR; Pepys MB; Hawkins PN
    Lancet; 2001 Jul; 358(9275):24-9. PubMed ID: 11454373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enzyme-linked immunosorbent assay of serum protein SAA in rhesus monkeys with secondary amyloidosis.
    Doepel FM; Glorioso JC; Newcomer CE; Skinner M; Abrams GD
    Lab Invest; 1981 Jul; 45(1):7-13. PubMed ID: 7253566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amyloid fibril protein AA in Papua New Guinean amyloidosis.
    Anders RF; Price MA; Wilkey IS; Husby G; Takitaki F; Natvig JB; McAdam KP
    Clin Exp Immunol; 1976 Apr; 24(1):49-53. PubMed ID: 820500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The value of the levels of acute phase reactants for the prediction of familial Mediterranean fever associated amyloidosis: a case control study.
    Yalçinkaya F; Cakar N; Acar B; Tutar E; Güriz H; Elhan AH; Oztürk S; Kansu A; Ince E; Atalay S; Girgin N; Doğru U; Aysev D; Ekim M
    Rheumatol Int; 2007 Apr; 27(6):517-22. PubMed ID: 17103173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of amyloid proteins AA and SAA as apolipoproteins of high density lipoprotein (HDL). Displacement of SAA from the HDL-SAA complex by apo AI and apo AII.
    Husebekk A; Skogen B; Husby G
    Scand J Immunol; 1987 Apr; 25(4):375-81. PubMed ID: 3107118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation of a low-molecular-weight serum component antigenically related to an amyloid fibril protein of unknown origin.
    Linke RP; Sipe JD; Pollock PS; Ignaczak TF; Glenner GG
    Proc Natl Acad Sci U S A; 1975 Apr; 72(4):1473-6. PubMed ID: 805429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amyloid-related serum protein (SAA) in patients with inherited amyloidosis and certain viral conditions.
    Meretoja J; Natvig JB; Husby G
    Scand J Immunol; 1976; 5(1-2):169-74. PubMed ID: 1083557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Murine model for human secondary amyloidosis: genetic variability of the acute-phase serum protein SAA response to endotoxins and casein.
    McAdam KP; Sipe JD
    J Exp Med; 1976 Oct; 144(4):1121-7. PubMed ID: 978136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and characterization of different amyloid fibril proteins in tissue sections.
    Cornwell GG; Husby G; Westermark P; Natvig JB; Michaelsen TE; Skogen B
    Scand J Immunol; 1977; 6(11):1071-80. PubMed ID: 413186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased circulating serum amyloid A protein derivatives in rheumatoid arthritis patients with secondary amyloidosis.
    Migita K; Eguchi K; Tsukada T; Kawabe Y; Takashima H; Mine M; Aoyagi T; Ichinose Y; Nagataki S
    Lab Invest; 1996 Sep; 75(3):371-5. PubMed ID: 8804360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levels of the serum amyloid A protein (SAA) in normal persons of different age groups.
    Hijmans W; Sipe JD
    Clin Exp Immunol; 1979 Jan; 35(1):96-100. PubMed ID: 428149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural history and outcome in systemic AA amyloidosis.
    Lachmann HJ; Goodman HJ; Gilbertson JA; Gallimore JR; Sabin CA; Gillmore JD; Hawkins PN
    N Engl J Med; 2007 Jun; 356(23):2361-71. PubMed ID: 17554117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three assays for the characterization and quantitation of human serum amyloid A.
    Marhaug G
    Scand J Immunol; 1983 Oct; 18(4):329-38. PubMed ID: 6417768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amyloid fibril protein subunit, "protein AS": distribution in tissue and serum in different clinical types of amyloidosis including that associated with myelomatosis and Waldenström's macroglobulinamia.
    Husby G; Sletten K; Michaelsen TE; Natvig JB
    Scand J Immunol; 1973; 2(4):395-404. PubMed ID: 4203674
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.